Ibrushil 140 mg Capsule
$101,89
$79,47
Ibrushil 140 mg capsule is a targeted anti-cancer treatment designed to combat various adult blood cancers, including mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and Waldenström's macroglobulinemia (WM). The active ingredient in Ibrushil functions by effectively inhibiting protein kinase activity, which plays a crucial role in the growth and survival of cancer cells. This mechanism helps to disrupt the cancerous cell cycle, leading to reduced tumor progression and improved patient outcomes. While Ibrushil offers promising results in managing these malignancies, it is essential for patients to discuss potential side effects and contraindications with their healthcare provider. Regular monitoring and adherence to prescribed dosage are vital to maximize the benefits while minimizing risks. If you're seeking a reliable option for managing specific blood cancers, Ibrushil may be an integral part of your treatment plan. Always consult your physician to ensure it aligns with your individual health needs and to address any concerns you may have about its use.
數量
Active Pharmaceutical Ingredient
Uses
• Ibrushil 140 mg capsule is primarily used in the treatment of chronic lymphocytic leukemia (CLL). This medication works by targeting specific cancer cells, helping to slow down their growth and proliferation. Patients with CLL may experience an improved quality of life as Ibrushil 140 mg capsule effectively manages their symptoms. It is often prescribed when other treatment options have been explored.
• Another significant use of Ibrushil 140 mg capsule is in the management of mantle cell leukemia. This aggressive form of leukemia requires prompt and effective treatment strategies. By utilizing Ibrushil 140 mg capsule, healthcare providers aim to control the progression of the disease and enhance patient outcomes. The medication supports the body's fight against this challenging condition.
• Ibrushil 140 mg capsule is also indicated for patients diagnosed with Waldenström's macroglobulinemia. This rare type of blood cancer can lead to various complications, and timely intervention is crucial. The administration of Ibrushil 140 mg capsule can help in reducing the levels of abnormal proteins in the blood, alleviating symptoms associated with the disease. It serves as a vital component of a comprehensive treatment plan.
• In clinical settings, Ibrushil 140 mg capsule may be utilized as part of a combination therapy regimen for hematological malignancies. This approach can enhance the overall effectiveness of treatment strategies for conditions like CLL, mantle cell leukemia, and Waldenström's macroglobulinemia. Physicians often choose Ibrushil 140 mg capsule for its ability to work synergistically with other agents. This can lead to better management of the disease and improved patient outcomes.
Benefits
Ibrushil 140 mg Capsule helps in treating blood cancer in patients who were not able to recover from previous medications. It helps to prevent the cancer cells to grow and multiply.
Side Effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine:
Most Common Side Effects
• Swollen feet and ankle
• Body pain Blurred Vision
• Vomiting
• Nausea
• Pneumonia
• Bloody Urine
• Constipation
• Breathlessness
• Bruises and Rashes
• Tiredness
• Numbness and Weakness
• Mouth Sores
Common Side Effects
• Low Count of Blood Cells
• High Blood Pressure
• Tumor Lysis Syndrome
• Allergic Reactions
• Infections
• Heart Problems
How To Use
Ibrushil 140 mg Capsule can be taken without or with food, as advised by your doctor. You must follow every guideline of your doctor strictly to get the best results.
Safety Advice
Not Found